European regulators prepare for AI in pharma
European Pharmaceutical Review
DECEMBER 19, 2023
The workplan, which runs until 2028, will help the European medicines regulatory network (EMRN) embrace the opportunities of AI for personal productivity, automating processes and systems, increasing insights into data and supporting more robust decision-making to benefit public and animal health.
Let's personalize your content